Cargando…
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial
Cell therapy trials for heart failure (HF) have shown modest improvement; however, the mechanisms underlying improvement in some patients but not others are not well understood. Although immune cells are important in the course of HF, our understanding of the immune processes in HF is limited. The o...
Autores principales: | Chacon Alberty, Lourdes, Perin, Emerson C., Willerson, James T., Gahremanpour, Amir, Bolli, Roberto, Yang, Phillip C., Traverse, Jay H., Lai, Dejian, Pepine, Carl J., Taylor, Doris A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446350/ https://www.ncbi.nlm.nih.gov/pubmed/34540912 http://dx.doi.org/10.3389/fcvm.2021.698088 |
Ejemplares similares
-
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
por: Bolli, Roberto, et al.
Publicado: (2020) -
Sex-Based Differences in Autologous Cell Therapy Trials in Patients With Acute Myocardial Infarction: Subanalysis of the ACCRUE Database
por: Haller, Paul M., et al.
Publicado: (2021) -
Mining the Mesenchymal Stromal Cell Secretome in Patients with Chronic Left Ventricular Dysfunction
por: Morrissey, Jacquelynn, et al.
Publicado: (2022) -
Building biorepositories in the midst of a pandemic
por: Croker, Jennifer A., et al.
Publicado: (2021) -
The time is right for an Antarctic biorepository network
por: O’Brien, Kristin M., et al.
Publicado: (2022)